The Balanced Opioid Initiative: Prescriber-Peer Consulting Model: Session 1, 6/2/2021
This activity is intended for physicians, physician assistants, and other interested health professionals.
ELEMENTS OF COMPETENCE
This activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, and medical knowledge. This activity also focuses on the interprofessional competency of teams/teamwork.
The Balanced Opioid Initiative: Prescriber-Peer Consulting Model is designed to address the following for the healthcare team:
- Identify and treat complex chronic pain patients in accordance with the CDC guidelines for opioid prescribing in primary care
- Enhance the ability to navigate difficult conversations with complex chronic pain patients surrounding tapering of opioid and/or benzodiazepine doses
- Determine best treatment plan options for inherited patients who have been prescribed high-dose opioids or co-prescribed opioids
- Welcome and Introductions
- Introduce Prescriber Peer Consulting
- Pre-Session Survey
- Pre-Made Case Using the STAR Model
- Discuss Factors and How They Relate to the Topic and Problems that Prescribers are Experiencing
- Post-Session Survey
FACULTY AND PLANNING COMMITTEE
- Randall Brown, MD, PhD, Associate Professor, University of Wisconsin School of Medicine and Public Health
- Jillian Landeck, MD, Assistant Professor, University of Wisconsin School of Medicine and Public Health
- Lynn Madden, PhD, Researcher, University of Wisconsin School of Medicine and Public Health
- Andrew Cohen, PharmD, Pharmacy Clinical Coordinator, Bellin Health
- Andrew Quanbeck, PhD, Assistant Professor, University of Wisconsin School of Medicine and Public Health
- Nicholas Schumacher, Research Specialist, University of Wisconsin School of Medicine and Public Health
- Sheila Weix, MSN, RN, CARN, Director of Substance Abuse Services - Alcohol & Drug Recovery Centers, Marshfield Clinic
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this continuing education (CE) activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this educational activity, all conflicts of interest have been resolved.
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
|In support of improving patient care, the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
CREDIT DESIGNATION STATEMENTS
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .1 CEU or 1 hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™